PALERMO, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 270
NA - Nord America 142
AS - Asia 106
SA - Sud America 3
Totale 521
Nazione #
US - Stati Uniti d'America 137
IT - Italia 110
SG - Singapore 54
DE - Germania 47
IE - Irlanda 33
RU - Federazione Russa 23
HK - Hong Kong 20
CN - Cina 18
SE - Svezia 17
GB - Regno Unito 15
FI - Finlandia 9
ID - Indonesia 7
CA - Canada 5
ES - Italia 3
IN - India 3
AR - Argentina 2
AT - Austria 2
GR - Grecia 2
NL - Olanda 2
PT - Portogallo 2
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
FR - Francia 1
IQ - Iraq 1
JP - Giappone 1
LK - Sri Lanka 1
PK - Pakistan 1
PL - Polonia 1
Totale 521
Città #
Singapore 51
Frankfurt am Main 42
Milan 39
Dublin 32
New York 18
Santa Clara 18
Hong Kong 14
Shanghai 13
London 10
Helsinki 8
Monza 8
Ashburn 7
Jakarta 7
Rome 7
Central 6
Chicago 6
Chandler 5
Florence 5
Naples 5
Bari 4
Princeton 4
Seregno 4
Ann Arbor 3
Beijing 3
Boardman 3
Carate Brianza 3
Cossato 3
Los Angeles 3
Modena 3
Toronto 3
Acquaviva delle Fonti 2
Alzano Lombardo 2
Athens 2
Catania 2
Fairfield 2
Lawrence 2
Lisbon 2
Mumbai 2
Seattle 2
Seville 2
Taranto 2
Vienna 2
Vimercate 2
Washington 2
Andover 1
Atlanta 1
Belsize Park 1
Bonndorf 1
Brescia 1
Brno 1
Caronno Pertusella 1
Castiglione del Lago 1
Council Bluffs 1
Dalian 1
Dambulla 1
Dottingen 1
Foggia 1
Garbagnate Milanese 1
Genoa 1
Groningen 1
Hounslow 1
Houston 1
Huizen 1
Islamabad 1
Jasper 1
Kemerovo 1
Lappeenranta 1
Lentate sul Seveso 1
Madinat Babil 1
Medolago 1
Montrouge 1
Munich 1
Padova 1
Phoenix 1
Pune 1
Richterswil 1
San Biagio di Callalta 1
San Diego 1
San Francisco 1
Tallinn 1
Tappahannock 1
Terni 1
Tokyo 1
Tomares 1
Treviso 1
Trois-Rivières 1
Turin 1
Windsor 1
Totale 409
Nome #
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 152
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 107
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 84
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 58
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 54
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 42
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 42
Totale 539
Categoria #
all - tutte 3.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 0 0 0 0 0 9 3 0 2 3
2022/2023178 6 11 13 15 33 34 10 11 7 13 9 16
2023/2024173 5 14 18 22 19 37 25 3 9 6 5 10
2024/2025171 21 35 33 22 31 25 4 0 0 0 0 0
Totale 539